
Our Pharmaceuticals business is divided into six core areas, Cardiovascular & Metabolism; Immunology; Infectious Diseases & Vaccines; Neuroscience; Oncology; and Pulmonary Hypertension. We seek innovation across all of these areas where there is significant unmet patient need.
We are also pioneering Data Science and digital healthcare and reimagining how we Discover, Develop & Supply transformational medicines to patients around the world.
CLICK a circle below to see the diseases we are targeting.
-
Cardivascular and Thrombosis,
Retinal Diseases,
Metabolism/NASH,
Renal DiseaseCARDIOVASCULAR, METABOLISM AND RETINA -
Gastroenterology,
Rheumatology & Maternal-fetal immunology,
Immuno Dermatology,
Autoantibody pathwayImmunology -
Viral Hepatitis & Adjacent Liver Diseases,
Prevention & Treatment of Viral & Bacterial Respiratory Infections,
Adjuvants, Novel Viral Vectors & Vaccine TechnologiesInfectious
Diseases and Vaccines -
Mood Disorders,
Neurodegenerative Disorders including Multiple Sclerosis,
SchizophreniaNeuroscience -
Prostate Cancer,
Hematologic Malignancies,
Solid Tumor Targeted Therapy,
Immuno-OncologyOncology -
Pulmonary Hypertension (all groups), Adjacent rare cardiopulmonary diseasesPulmonary Hypertension
-
• Small molecule & protein therapeutics
• mRNA & siRNA therapeutics
• Cell & gene therapeutics
• Data & analyticsDiscovery, Product Development & Supply -
• Drug Discovery: AI & Machine Learning (ML) to drive:
- High-value biological insights & targets
- Reduced cycle time & improved NME quality
• Drug Development: AI & ML to drive:
- Improved clinical trial design, including early detection, better endpoints & patient stratification
- Accelerated clinical trial operations
- Enhanced Diversity & Inclusion
• Real-World Evidence (RWE) & external control arms to augment regulatory submissions & internal decisions
• Digital health & treatments, Software as a Medical Device & decentralized trials to enhance careData Science
Johnson & Johnson Innovation is comprised of a family of complementary teams that bring meaningful solutions and flexible approaches to support collaboration. From incubation facilities to early-stage investing – from venture funding to acquisition, our teams offer partners a full range of capabilities.
Make the Connection
We look forward to our first discussion. If you would like to discuss a collaboration,
please connect with us and we will schedule a call soon.